Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Liraglutide and sitagliptin mechanistic safety study in insulin-naive adults with type 2 diabetes
NL-OMON41271Phase 4Active, not recruiting
- Sponsor
- Vrije University Medical Center
- Start
- May 2013
- Modality
- Peptides, Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of liraglutide, sitagliptin, exenatide, NG-monomethyl-L-arginine in type 2 diabetes mellitus (T2DM), sponsored by Vrije University Medical Center. Started May 2013; status: active, not recruiting.
02
Drugs
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NL-OMON41271.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON41271.